← Back to Search

Remote Monitoring for Alcoholism

N/A
Recruiting
Research Sponsored by Mikhail N Koffarnus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a total of 12 assessment sessions spanning over a 66 week period.
Awards & highlights

Summary

This trial will use a smartphone app and breathalyzer to remotely monitor alcohol abstinence in order to help people with alcohol dependence.

Who is the study for?
This trial is for adults who drink heavily at least three times a week and want to stop drinking. They must have an alcohol use disorder with alcohol as their main substance of abuse, but not be in another treatment program or need medication for detox.
What is being tested?
The study tests if using a smartphone app and breathalyzer can help people stay away from alcohol by giving them money rewards for staying sober. This could make it easier to treat more people with alcohol dependence effectively.
What are the potential side effects?
Since the intervention involves behavioral incentives rather than medication, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a total of 12 assessment sessions spanning over a 66 week period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and a total of 12 assessment sessions spanning over a 66 week period. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pattern of abstinence from alcohol during intervention
Treatment acceptability

Trial Design

5Treatment groups
Active Control
Placebo Group
Group I: Group BActive Control1 Intervention
Group B will receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples, but will not receive the payments if they provide positive samples or fail to provide samples in a timely manner for the first 3 weeks of the intervention.For the remaining 9 weeks they will not be required to submit breathalyzer samples.
Group II: Group EActive Control1 Intervention
Group E will have no intervention, they will only complete assessment sessions.
Group III: Group AActive Control1 Intervention
Group A will receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples, but will not receive the payments if they provide positive samples or fail to provide samples in a timely manner for the first 3 weeks of the intervention. For the remaining 9 weeks they will continue to receive incentives for submitting negative samples.
Group IV: Group DPlacebo Group1 Intervention
Group D will receive nearly immediate monetary payments over the internet each day they remotely provide breathalyzer samples regardless of the alcohol content, but will not receive the payments if they fail to provide samples in a timely manner for the first 3 weeks of the intervention. For the remaining 9 weeks they will not be required to submit breathalyzer samples.
Group V: Group CPlacebo Group1 Intervention
Group C will receive nearly immediate monetary payments over the internet each day they remotely provide breathalyzer samples regardless of the alcohol content, but will not receive the payments if they fail to provide samples in a timely manner for the first 3 weeks of the intervention. For the remaining 9 weeks they will continue to receive incentives for submitting on time samples regardless of alcohol content.

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
823 Previous Clinical Trials
1,161,106 Total Patients Enrolled
432 Trials studying Alcoholism
778,267 Patients Enrolled for Alcoholism
Mikhail N KoffarnusLead Sponsor
2 Previous Clinical Trials
703 Total Patients Enrolled
1 Trials studying Alcoholism
230 Patients Enrolled for Alcoholism

Media Library

Contingency management Clinical Trial Eligibility Overview. Trial Name: NCT03883126 — N/A
Alcoholism Research Study Groups: Group D, Group B, Group E, Group C, Group A
Alcoholism Clinical Trial 2023: Contingency management Highlights & Side Effects. Trial Name: NCT03883126 — N/A
Contingency management 2023 Treatment Timeline for Medical Study. Trial Name: NCT03883126 — N/A
~35 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top